These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8867521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients.
    Silvestri RC, Bromfield EB, Khoshbin S.
    Ann Pharmacother; 1998 Nov; 32(11):1147-51. PubMed ID: 9825078
    [Abstract] [Full Text] [Related]

  • 4. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J, Urban A, Valis M, Malý R, Tůma I, Hosák L.
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [Abstract] [Full Text] [Related]

  • 5. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.
    Wagner ML, Defilippi JL, Menza MA, Sage JI.
    J Neuropsychiatry Clin Neurosci; 1996 Mar; 8(3):276-80. PubMed ID: 8854298
    [Abstract] [Full Text] [Related]

  • 6. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O, Weiner RD, McEvoy JP.
    Biol Psychiatry; 1997 Jul 15; 42(2):132-7. PubMed ID: 9209730
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term outcome of clozapine use for psychosis in parkinsonian patients.
    Fernandez HH, Donnelly EM, Friedman JH.
    Mov Disord; 2004 Jul 15; 19(7):831-833. PubMed ID: 15254945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of psychotic complications of Parkinson disease with clozapine].
    Ozsancak C, Auzou P, Ronzière T, Hannequin D, Augustin P.
    Presse Med; 1997 Nov 01; 26(33):1599-602. PubMed ID: 9452762
    [No Abstract] [Full Text] [Related]

  • 11. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    Dias Alves M, Micoulaud-Franchi JA, Simon N, Vion-Dury J.
    J Clin Psychopharmacol; 2018 Dec 01; 38(6):555-562. PubMed ID: 30247179
    [Abstract] [Full Text] [Related]

  • 12. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb 01; 11(57):1-6. PubMed ID: 11985366
    [Abstract] [Full Text] [Related]

  • 13. Clozapine-induced cataplexy.
    Desarkar P, Goyal N, Khess CR.
    J Neuropsychiatry Clin Neurosci; 2007 Feb 01; 19(1):87-8. PubMed ID: 17308237
    [No Abstract] [Full Text] [Related]

  • 14. Clinical utility of clozapine in 16 patients with neurological disease.
    Duffy JD, Kant R.
    J Neuropsychiatry Clin Neurosci; 1996 Feb 01; 8(1):92-6. PubMed ID: 8845709
    [Abstract] [Full Text] [Related]

  • 15. EEG alterations and seizures during treatment with clozapine. A retrospective study of 283 patients.
    Günther W, Baghai T, Naber D, Spatz R, Hippius H.
    Pharmacopsychiatry; 1993 May 01; 26(3):69-74. PubMed ID: 8415896
    [Abstract] [Full Text] [Related]

  • 16. Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine.
    Onofrj M, Thomas A, Bonanni L, Iacono D, Gambi F.
    Neurol Sci; 2000 Aug 01; 21(4):209-15. PubMed ID: 11214659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.